Volume 7, Issue 4, July 2018, Page: 134-141
Hepatoprotective Effect of an Antrodia cinnamomea Product Via a Novel Process on Carbon Tetrachloride-Induced Hepatotoxicity in Rats
Hong-Ying Hsiao, Department of Food Science, National Chiayi University, Chiayi, Taiwan
Yih-Ming Weng, Department of Food Science, National Chiayi University, Chiayi, Taiwan
Received: Aug. 9, 2018;       Published: Aug. 13, 2018
DOI: 10.11648/j.ijnfs.20180704.14      View  618      Downloads  45
Antrodia cinnamomea, causing a brown heart rot of Cinnamomum kanehirai Hay. endemic to Taiwan, was reported to have several biological activities for treating liver diseases, inflammation, tumors, et al. It was believed that wild or wood-cultured A.cinnamomea on C.kanehirai Hay. was better than by other means. However, C.kanehirai Hay. was rare and expensive, that resulted in a higher price of wild or wood-cultured A.cinnamomea. Hence, a novel process was developed to spray solid-state-cultured A.cinnamomea extracts on wood-cultured A.cinnamomea powder to make a high quality and low price product. The purpose of the study was to evaluate its hepatoprotection against carbon tetrachloride-induced hepatotoxicity in rats. Results revealed that aspartate aminotransferase (AST) and alanine aminotransferase (ALT) of Sprague Dawley rats administered 20% carbon tetrachloride (CCl4) twice a week, when the rats was also administered 413.4 or 1033.5 mg/kg body weight (BW) A.cinnamomea daily for 8 weeks, were significantly reduced in serum. Administration of 1033.5 mg/kg BW A.cinnamomea daily would not only reduce the rats’ liver and spleen swelling, liver fibrosis, and level of hydroxyproline, but increase activities of superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, and glutathione. In conclusion, the A.cinnamomea product via the novel process at 1033.5 mg/kg BW had hepatoprotective effects on carbon tetrachloride-induced hepatotoxicity in rats.
Antrodia cinnamomea, Hepatoprotection, Novel Process, Carbon Tetrachloride
To cite this article
Hong-Ying Hsiao, Yih-Ming Weng, Hepatoprotective Effect of an Antrodia cinnamomea Product Via a Novel Process on Carbon Tetrachloride-Induced Hepatotoxicity in Rats, International Journal of Nutrition and Food Sciences. Vol. 7, No. 4, 2018, pp. 134-141. doi: 10.11648/j.ijnfs.20180704.14
A. J. Hsiao, L. H. Chen, and T. H. Lu, “Ten leading causes of death in Taiwan: A comparison of two grouping lists,” J. Formos. Med. Assoc., vol. 114, no. 8, pp. 679-680, 2015.
C. J. L. Murray, T. Vos, R. Lozano, M. Naghavi, A. D. Flaxman, C. Michaud, M. Ezzati, K. Shibuya, J. A. Salomon, S. Abdalla et al., “Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010,” Lancet, vol. 380, no. 9859, pp. 2197-2223, 2012/12/15/, 2012.
A. A. Mokdad, A. D. Lopez, S. Shahraz, R. Lozano, A. H. Mokdad, J. Stanaway, C. J. L. Murray, and M. Naghavi, “Liver cirrhosis mortality in 187 countries between 1980 and 2010: A systematic analysis,” BMC Med., vol. 12, no. 1, pp. 145, 2014.
J. Wiegand, and T. Berg, “The etiology, diagnosis and prevention of liver cirrhosis,” Dtsch. Ärztebl. Int., vol. 110, no. 6, pp. 85-91, 2013.
P. E. Chang, G. W. Wong, J. W. Q. Li, H. F. Lui, W. C. Chow, and C. K. Tan, “Epidemiology and clinical evolution of liver cirrhosis in Singapore,” Ann. Acad. Med. Singapore, vol. 44, no. 6, pp. 218-225, 2015.
P. L. Gonçalves, M. d. P. Zago-Gomes, C. C. Marques, A. T. Mendonça, C. S. Gonçalves, and F. E. L. Pereira, “Etiology of liver cirrhosis in Brazil: Chronic alcoholism and hepatitis viruses in liver cirrhosis diagnosed in the state of Espírito Santo,” Clinics, vol. 68, no. 3, pp. 291-295, 2013.
Z. H. Ao, Z. H. Xu, Z. M. Lu, H. Y. Xu, X. M. Zhang, and W. F. Dou, “Niuchangchih (Antrodia camphorata) and its potential in treating liver diseases,” J. Ethnopharmacol., vol. 121, no. 2, pp. 194-212, 2009.
C. Y. Chang, Z. N. Huang, H. H. Yu, L. H. Chang, S. L. Li, Y. P. Chen, K. Y. Lee, and J. J. Chuu, “The adjuvant effects of Antrodia camphorata extracts combined with anti-tumor agents on multidrug resistant human hepatoma cells,” J. Ethnopharmacol., vol. 118, no. 3, pp. 387-395, 2008.
F. C. Yang, Y. H. Yang, and H. C. Lu, “Enhanced antioxidant and antitumor activities of Antrodia cinnamomea cultured with cereal substrates in solid state fermentation,” Biochem. Eng. J., vol. 78, pp. 108-113, 2013.
D. Z. Liu, H. J. Liang, C. H. Chen, C. H. Su, T. H. Lee, C. T. Huang, W. C. Hou, S. Y. Lin, W. B. Zhong, P. J. Lin et al., “Comparative anti-inflammatory characterization of wild fruiting body, liquid-state fermentation, and solid-state culture of Taiwanofungus camphoratus in microglia and the mechanism of its action,” J. Ethnopharmacol., vol. 113, no. 1, pp. 45-53, 2007.
C. H. Chang, H. E. Wang, P. Y. Liaw, C. C. Peng, and R. Y. Peng, “Antrodia cinnamomea exhibits a potent neuroprotective effect in the PC12 cell-Aβ25-35 model – pharmacologically through adenosine receptors and mitochondrial pathway,” Planta Med., vol. 78, no. 17, pp. 1813-1823, 2012.
E. Xia, G. Rao, H. van Remmen, A. R. Heydari, and A. Richardson, “Activities of antioxidant enzymes in various tissues of male Fischer 344 rats are altered by food restriction,” J. Nutr., vol. 125, no. 2, pp. 195-201, 1995.
H. Aebi, “Catalase in vitro,” Methods Enzymol., vol. 105, pp. 121-126, 1984.
P. J. Hissin, and R. Hilf, “A fluorometric method for determination of oxidized and reduced glutathione in tissues,” Anal. Biochem., vol. 74, no. 1, pp. 214-226, 1976.
R. E. Neuman, and M. A. Logan, “The determination of hydroxyproline,” J. Biol. Chem., vol. 184, pp. 299-306, 1950.
G. Boigk, L. Stroedter, H. Herbst, J. Waldschmidt, E. O. Riecken, and D. Schuppan, “Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats,” Hepatology, vol. 26, no. 3, pp. 643-649, 1997.
F. Wróblewski, and J. S. LaDue, “Serum glutamic pyruvic transaminase (SGP-T) in hepatic disease: A preliminary report,” Ann. Intern. Med., vol. 45, no. 5, pp. 801-811, 1956.
T. Matsuzawa, Y. Hayashi, M. Nomura, T. Unno, T. Igarashi, T. Furuya, K. Sekita, A. Ono, Y. Kurokawa, and Y. Hayashi, “A survey of the values of clinical chemistry parameters obtained for a common rat blood sample in ninety-eighty Japanese laboratories,” J. Toxicol. Sci., vol. 22, no. 1, pp. 25-45, 1997.
H. W. Chiu, and K. F. Hua, “Hepatoprotective effect of wheat-based solid-state fermented Antrodia cinnamomea in carbon tetrachloride-induced liver injury in rat,” PLoS ONE, vol. 11, no. 4, pp. e0153087, 2016.
Y. L. Shih, M. F. Wu, C. H. Lee, M. Y. Yeh, J. Chou, J. Y. Liu, H. F. Lu, Y. P. Huang, N. C. Liao, and J. G. Chung, “Antrodia cinnamomea reduces carbon tetrachloride-induced hepatotoxicity in male Wister rats,” In Vivo, vol. 31, pp. 877-884, 2017.
F. de Ritis, G. Giusti, F. Piccinino, and L. Cacciatore, “Biochemical laboratory tests in viral hepatitis and other hepatic diseases: Evaluation and follow-up,” Bull. World Health Organ., vol. 32, no. 1, pp. 59-72, 1965.
A. L. B. Williams, and J. H. Hoofnagle, “Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis: Relationship to cirrhosis,” Gastroenterology, vol. 95, no. 3, pp. 734-739, 1988.
K. S. Parmar, G. K. Singh, G. P. Gupta, T. Pathak, and S. Nayak, “Evaluation of de Ritis ratio in liver-associated diseases,” Int. J. Med. Sci. Public Health, vol. 5, no. 9, pp. 1783-1788, 2016.
M. A. Hyder, M. Hasan, and A. H. Mohieldein, “Comparative levels of ALT, AST, ALP and GGT in liver associated diseases,” Euro. J. Exp. Bio., vol. 3, no. 2, pp. 280-284, 2013.
B. M. Lee, W. C. Lee, J. Y. Jang, P. Ahn, J. N. Kim, S. W. Jeong, E. J. Park, S. H. Lee, S. G. Kim, S. W. Cha et al., “Clinical features of drug-induced liver injury according to etiology,” J. Korean Med. Sci., vol. 30, pp. 1815-1820, 2015.
E. Björnsson, and R. Olsson, “Outcome and prognostic markers in severe drug-induced liver disease,” Hepatology, vol. 42, no. 2, pp. 481-489, 2005.
P. Deepa, and N. Sasivathanam, “A study of AST/ALT ratio in metabolic syndrome,” Int. J. Contemp. Med. Res., vol. 4, no. 1, pp. 28-30, 2017.
E. Giannini, D. Risso, F. Botta, B. Chiarbonello, A. Fasoli, F. Malfatti, P. Romagnoli, E. Testa, P. Ceppa, and R. Testa, “Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease,” Arch. Intern. Med., vol. 163, no. 2, pp. 218-224, 2003.
P. S. Alves, E. A. Camilo, and J. P. Correia, “The SGOT/SGPT ratio in alcoholic liver disease,” Acta Méd. Port., vol. 3, no. 4, pp. 255-260, 1981.
S. L. Friedman, “Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury,” J. Biol. Chem., vol. 275, no. 4, pp. 2247-2250, 2000.
R. A. Pierce, M. R. Glaug, R. S. Greco, J. W. Mackenzie, C. D. Boyd, and S. B. Deak, “Increased procollagen mRNA levels in carbon tetrachloride-induced liver fibrosis in rats,” J. Biol. Chem., vol. 262, no. 4, pp. 1652-1658, 1987.
R. C. Benyon, and J. P. Iredale, “Is liver fibrosis reversible?,” Gut, vol. 46, no. 4, pp. 443-446, 2000.
M. M. Shiu, B. Y. Huang, C. C. Liu, C. S. Liao, and M. C. Lin, “Protective effect of Antrodia camphorate on the tissues of brain, kidney, lung, and the liver is correlated with declining lipid peroxidation,” Am. J. Lab. Med., vol. 3, no. 1, pp. 6-10, 2018.
B. Y. Huang, C. C. Liu, Z. Y. Jian, and M. C. Lin, “Antrodia camphorata declines oxidative stress and enhances antioxidant enzyme activity in the brain cortex of rats,” Am. J. Lab. Med., vol. 1, no. 3, pp. 29-33, 2016.
M. Boll, L. W. D. Weber, E. Becker, and A. Stampfl, “Mechanism of carbon tetrachloride-induced hepatotoxicity. Hepatocellular damage by reactive carbon tetrachloride metabolites,” Z. Naturforsch., vol. 56C, no. 7-8, pp. 649-659, 2001.
K. R. Ritesh, A. Suganya, H. V. Dileepkumar, Y. Rajashekar, and T. Shivanandappa, “A single acute hepatotoxic dose of CCl4 causes oxidative stress in the rat brain,” Toxicol. Rep., vol. 2, pp. 891-895, 2015.
J. L. Shen, Q. Wang, Y. Zhang, and H. Y. Ma, “Discussion on the use of Chinese medicine and institutional innovation in community health management,” Sci. J. Public Health, vol. 4, no. 3, pp. 235-240, 2016.
Browse journals by subject